1. Home
  2. ELVN vs TDOC Comparison

ELVN vs TDOC Comparison

Compare ELVN & TDOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • TDOC
  • Stock Information
  • Founded
  • ELVN 2016
  • TDOC 2002
  • Country
  • ELVN United States
  • TDOC United States
  • Employees
  • ELVN N/A
  • TDOC N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • TDOC Medical/Nursing Services
  • Sector
  • ELVN Health Care
  • TDOC Health Care
  • Exchange
  • ELVN Nasdaq
  • TDOC Nasdaq
  • Market Cap
  • ELVN 1.2B
  • TDOC 1.4B
  • IPO Year
  • ELVN 2020
  • TDOC 2015
  • Fundamental
  • Price
  • ELVN $20.81
  • TDOC $9.18
  • Analyst Decision
  • ELVN Strong Buy
  • TDOC Buy
  • Analyst Count
  • ELVN 5
  • TDOC 17
  • Target Price
  • ELVN $41.20
  • TDOC $9.80
  • AVG Volume (30 Days)
  • ELVN 563.5K
  • TDOC 7.1M
  • Earning Date
  • ELVN 11-12-2025
  • TDOC 10-29-2025
  • Dividend Yield
  • ELVN N/A
  • TDOC N/A
  • EPS Growth
  • ELVN N/A
  • TDOC N/A
  • EPS
  • ELVN N/A
  • TDOC N/A
  • Revenue
  • ELVN N/A
  • TDOC $2,542,268,000.00
  • Revenue This Year
  • ELVN N/A
  • TDOC $0.09
  • Revenue Next Year
  • ELVN $20.05
  • TDOC $1.09
  • P/E Ratio
  • ELVN N/A
  • TDOC N/A
  • Revenue Growth
  • ELVN N/A
  • TDOC N/A
  • 52 Week Low
  • ELVN $13.30
  • TDOC $6.35
  • 52 Week High
  • ELVN $30.03
  • TDOC $15.21
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 51.84
  • TDOC 53.90
  • Support Level
  • ELVN $19.02
  • TDOC $8.22
  • Resistance Level
  • ELVN $20.66
  • TDOC $9.77
  • Average True Range (ATR)
  • ELVN 1.00
  • TDOC 0.49
  • MACD
  • ELVN 0.09
  • TDOC 0.02
  • Stochastic Oscillator
  • ELVN 69.85
  • TDOC 30.85

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.

Share on Social Networks: